on203: the anti-oxmif antibody targeting solid tumors
Published 2 years ago • 109 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:45
the rationale behind the mif-targeting antibody on203 for solid tumors
-
1:02
the macrophage migration inhibitory factor (mif) as a therapeutic and diagnostic target
-
4:03
phase i/ii trial of zenocutuzumab for tumors with nrg1 fusions
-
32:34
tumor-derived antibodies for multifaceted immunotherapeutic targeting of human ovarian cancer
-
3:43
tumor-infiltrating lymphocytes act as prognostic biomarkers in advanced breast cancer
-
4:50
ngs across tumor types for trk inhibition
-
4:55
case 2: metastatic colon cancer, no molecular alterations
-
23:45
the inflammatory pathogenesis of cancer-progress in the gene specific targeting of mif
-
4:35
human tumor atlas network: constructing 3d maps of tumors could advance cancer treatments
-
0:46
the prognostic impact of tp53 mutation in mpns
-
1:55
mgus progression to overt myeloma: the tumor microenvironment
-
1:15
treating mesothelioma with checkpoint inhibitors
-
2:08
dr. jose baselga compares the mtor inhibitors temsirolimus and everolimus
-
12:11
gs3-09: "loss of asxl1 tumor suppressor promotes resistance to cdk4/6 inhibitors in er breast..."
-
0:54
expanding treatment choices and immunotherapy in non-melanoma skin cancers: 2022 esmo florida
-
1:20
impact of tp53 mutations on outcomes in myelofibrosis
-
4:00
quantitative microimmunohistochmiestry for the grading of immunostains on tumor tissues
-
20:10
multiple primary tumors
-
1:18
dr. overman on unmet needs with immunotherapy in mcrc